Physician Nathaniel Chin says repeat cognitive testing can show whether a person’s thinking is changing over time, beyond a single score.
One Cognitive Test Is A Snapshot — Two Is A Trajectory: A Physician’s Take
Browsing Category
Health Monitoring at Home
329 posts
More Medical Testing, More Problems
Public and media attention to the downsides of expanded medical testing is spiking. What is established, what is driving interest, and what remains unclear.
Nursing Home And Executives Agree To Pay $1M For Overbilling Allegations
Coverage interest is spiking around reports of a nursing home and executives agreeing to pay $1M over overbilling allegations; details remain unconfirmed.
How Drinking Affects Your Dementia Risk
Search and coverage interest is rising around alcohol and dementia risk, but the reason for the spike is unconfirmed.
How Home-Based Care Providers Clear Operational Bottlenecks
Coverage interest in home-based care operations is rising, but the reason for the spike and any specific provider developments remain unconfirmed.
Galil Importing Corp Recalls Lior Cinnamon Ground Seasoning Due To Elevated Lead Levels
Galil Importing Corp has recalled Lior Cinnamon Ground Seasoning after testing indicated elevated lead levels. Details on scope and risk remain limited.
3 Ways Your Brain Adapts After Emotional Abuse
Search and media interest is spiking in how the brain changes after emotional abuse. Here’s what research has long shown, and what remains unconfirmed.
Back And Shoulder Surgery Is Often Worse Than Useless
Emerging analysis suggests many back and shoulder surgeries may provide little benefit and could be worse than doing nothing, raising concerns among medical experts.
Empath Health Launches Dementia Services Tackling Frontline Crises, Avoidable Hospitalizations
Empath Health introduces new dementia services aimed at addressing frontline crises and reducing avoidable hospitalizations, marking a significant step in dementia care.
F.D.A. Advisory Panel Endorses Controversial Cancer Blood Test
An FDA advisory panel has recommended approval of a new cancer blood test amid debate over its accuracy and clinical value, sparking industry and patient interest.
